Mayi Arcellana-Panlilio
University of Calgary
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mayi Arcellana-Panlilio.
Biochemical and Biophysical Research Communications | 2008
Tessa N. Campbell; Alice Davy; Yiping Liu; Mayi Arcellana-Panlilio; Stephen M. Robbins
Eph receptor tyrosine kinases and their membrane-bound ligand ephrins form an essential cell communication system. Both ephrin classes have been shown to localize within cell surface lipid rafts, yet regulate different biological processes. In order to provide insight into this distinct behavior, we examined ephrin-A5 and B1 localization and signaling in murine fibroblasts and tissues. Results indicated that ephrin-A5 was constitutively present in detergent-resistant membrane fractions, while ephrin-B1 displayed translocation to membrane fractions upon stimulation. Ephrin-A5 and B1 were present in detergent-resistant membrane fractions with different buoyancies in vitro and in different raft fractions in vivo. Moreover, ephrin-A5 and B1 differentially influenced actin reorganization. Finally, microarray analysis revealed unique patterns of gene expression between the two ephrin classes. We thus demonstrate that distinct localization and compartmentalization provide insight into the subcellular basis for differential signaling observed in ephrin-A and B classes.
Genes, Chromosomes and Cancer | 2002
Mayi Arcellana-Panlilio; R. Maarten Egeler; Eva Ujack; Anthony M. Magliocco; Gavin C.E. Stuart; Stephen M. Robbins; Max J. Coppes
Granulosa cell tumors (GCTs) of the ovary are relatively rare and account for <5% of all ovarian cancers. The molecular pathogenesis of these tumors is not well understood. We tested the hypothesis that cyclin‐dependent kinase inhibitors, specifically the inhibitors of the cyclin‐dependent kinase 4 (INK4) family, are targets for altered gene expression in GCTs. The status of RB1, INK4A, INK4B, INK4C, INK4D, and ARF in 13 adult and 2 juvenile ovarian GCTs was determined by reverse transcription–polymerase chain reaction of total RNA and exon‐specific sequencing of genomic DNA. Tumors showing loss of INK4A expression were assayed further by exon‐deletion analysis and methylation‐specific PCR. None of the juvenile tumors demonstrated altered expression, but 7/12 (58%) adult GCTs lacked expression of INK4A, INK4B, or both. In one of these cases, we noted a homozygous deletion of the INK4A locus, and in the remaining tumors we found hypermethylation of the promoter region, a mechanism that can lead to gene inactivation. These data support a role for the INK4 family of CDK inhibitors in the biology of GCTs.
ACS Synthetic Biology | 2014
Ali Honarmand; Robert Matthew Mayall; Iain George; Lisa Oberding; Himika Dastidar; Jamie Fegan; Somshukla Chaudhuri; Justin Dole; Sharon Feng; Denny Hoang; Ruth Moges; Julie Osgood; Taylor Remondini; Wm. Keith van der Meulen; Su Wang; Chris Wintersinger; Amanda Zaparoli Zucoloto; Kate Chatfield-Reed; Mayi Arcellana-Panlilio; Anders Nygren
Transcription activator-like effectors (TALEs), originating from the Xanthomonas genus of bacteria, bind to specific DNA sequences based on amino acid sequence in the repeat-variable diresidue (RVD) positions of the protein. By altering these RVDs, it has been shown that a TALE protein can be engineered to bind virtually any DNA sequence of interest. The possibility of multiplexing TALEs for the purposes of identifying specific DNA sequences has yet to be explored. Here, we demonstrate a system in which a TALE protein bound to a nitrocellulose strip has been utilized to capture purified DNA, which is then detected using the binding of a second distinct TALE protein conjugated to a protein tag that is then detected by a dot blot. This system provides a signal only when both TALEs bind to their respective sequences, further demonstrating the specificity of the TALE binding.
bioRxiv | 2018
Xingyu Chen; Syeda Ibrahim; Alina Kunitskaya; Kaitlin Schaaf; Zi Fei Wang; Preetha Gopalakrishan; Maliyat Noor; Harry Wilton-Clark; Jacob Grainger; Alex Ivanova; Patricia Lim; Michaela Olsakova; Lalit Bharadwaj; Bilal Sher; David Feehan; Rachelle Varga; Mayi Arcellana-Panlilio
Space exploration has long been a source of inspiration, challenging scientists and engineers to find innovative solutions to various problems. One of the current focuses in space exploration is to send humans to Mars. However, the challenge of transporting materials to Mars and the need for waste management processes are two major obstacles for these long-duration missions. To address these two challenges a process called Astroplastic was developed that produces polyhydroxybutyrate (PHB) from solid human waste, which can be used to 3D print useful items for astronauts. PHB granules are naturally produced by bacteria such as Ralstonia eutropha and Pseudomonas aeruginosa for carbon and energy storage. The phaJ, phaC, and phaCBA genes were cloned from these native PHB-producing bacteria into Escherichia coli. These genes code for enzymes that aid in PHB production by converting products of glycolysis and β-oxidation pathways, such as acetyl-CoA and enoyl-CoA, into PHB. To ensure a continuous PHB production system and to eliminate the need for cell lysis to extract PHB, recombinant E. coli was engineered to use the genes in its natural type I secretion system to secrete PHB. The C-terminal of the HlyA secretion tag was fused to phasin (PhaP), a protein originally from R. eutropha. Phasin-HlyA electrostatically binds PHB granules and transports them outside of the cell. In addition to genetically engineering bacteria, a concept for start-to-finish PHB production process was designed. Integrating expert feedback and experimental results, conditions for each step of the process including the collection and storage of waste, volatile fatty acid (VFA) fermentation, VFA extraction, PHB fermentation, and PHB extraction were optimized. The optimized system will provide a sustainable and continuous PHB production system, which will address the problems of transportation costs and waste management for future space missions. Financial Disclosure Mindfuel Science Alberta Foundation Genome Alberta GenScript Polyferm Canada GeekStarter Alberta Integrated DNA Technologies University of Calgary University of Calgary Cumming School of Medicine University of Calgary Bachelor of Sciences University of Calgary Schulich School of Engineering University of Calgary O’Brien Centre for the Bachelor of Health Sciences City of Calgary Alberta Innovates The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests The authors have declared that no competing interests exist. Ethics Statement N/A Data Availability All data are freely available without restriction.
Biology of Reproduction | 1995
M.B. Harvey; Mayi Arcellana-Panlilio; X. Zhang; Gilbert A. Schultz; Andrew J. Watson
Biology of Reproduction | 1994
Andrew J. Watson; Patricia H. Watson; Mayi Arcellana-Panlilio; Deirdre Warnes; Simon K. Walker; Gilbert A. Schultz; David T. Armstrong; R.F. Seamark
Molecular Human Reproduction | 1995
M.B. Harvey; Kevin J. Leco; Mayi Arcellana-Panlilio; X. Zhang; Dylan R. Edwards; G.A. Schurtz
Molecular Reproduction and Development | 1993
Gilbert A. Schultz; Ann Hahnel; Mayi Arcellana-Panlilio; Liangsu Wang; Sabine Goubau; Andrew J. Watson; Mark Harvey
Carcinogenesis | 2005
Yan Zhou; Jing Zhang; Qiang Liu; Robert B. Bell; Daniel A. Muruve; Peter A. Forsyth; Mayi Arcellana-Panlilio; Stephen M. Robbins; V. Wee Yong
American Journal of Physiology-gastrointestinal and Liver Physiology | 2002
Mayi Arcellana-Panlilio; Stephen M. Robbins